Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.
01 1Pharmaceutical Works POLPHARMA
02 1Alchymars ICM SM Private Limited
03 1Aurobindo Pharma Limited
04 1Cipla Ltd.
05 1Hetero Drugs Limited
06 1Jubilant Pharmova Limited
07 1MYLAN LABORATORIES LIMITED
08 1Synthimed Labs Private Limited
09 1TAPI Croatia Industries Ltd.
01 1RISEDRONATE SODIUM HEMI-PENTAHYDRATE
02 1RISEDRONATE SODIUM HEMIPENTAHYDRATE
03 6Risedronate Sodium
04 1Risedronate Sodium Hemipentahydrate
01 6India
02 1Poland
03 1U.S.A
04 1Blank
Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.
RISEDRONATE SODIUM HEMI-PENTAHYDRATE
NDC Package Code : 12658-0604
Start Marketing Date : 1998-03-27
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 14998-0008
Start Marketing Date : 2010-09-07
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
RISEDRONATE SODIUM HEMI-PENTAHYDRATE
NDC Package Code : 65862-396
Start Marketing Date : 2024-01-10
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 53104-7653
Start Marketing Date : 2016-01-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65977-0092
Start Marketing Date : 2010-10-08
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65372-1113
Start Marketing Date : 2006-11-06
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65096-0110
Start Marketing Date : 2010-11-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
RISEDRONATE SODIUM HEMI-PENTAHYDRATE
NDC Package Code : 65015-679
Start Marketing Date : 2015-03-06
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 11722-077
Start Marketing Date : 2021-07-20
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
A Risedronate Sodium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Risedronate Sodium, including repackagers and relabelers. The FDA regulates Risedronate Sodium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Risedronate Sodium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Risedronate Sodium manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Risedronate Sodium supplier is an individual or a company that provides Risedronate Sodium active pharmaceutical ingredient (API) or Risedronate Sodium finished formulations upon request. The Risedronate Sodium suppliers may include Risedronate Sodium API manufacturers, exporters, distributors and traders.
click here to find a list of Risedronate Sodium suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Risedronate Sodium as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Risedronate Sodium API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Risedronate Sodium as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Risedronate Sodium and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Risedronate Sodium NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Risedronate Sodium suppliers with NDC on PharmaCompass.
We have 8 companies offering Risedronate Sodium
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
